과제정보
연구 과제 주관 기관 : 동아제약
참고문헌
- Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D. Prevalence of urinary tract infection in febrile infants. J Pediatr 1993;123:17-23 https://doi.org/10.1016/S0022-3476(05)81531-8
- Bauchner H, Philipp B, Dashefsky B, Klein JO. Prevalence of bacteriuria in febrile children. Pediatr Infect Dis J 1987; 6:239-42 https://doi.org/10.1097/00006454-198703000-00004
- Hoberman A, Wald ER. Treatment of urinary tract infections. Pediatr Infect Dis J 1999;18:1020-1 https://doi.org/10.1097/00006454-199911000-00018
- Larcombe J. Urinary tract infection in children. BMJ 1999; 319:1173-5 https://doi.org/10.1136/bmj.319.7218.1173
- Goldraich NP, Manfroi A. Febrile urinary tract infection : Escherichia coli susceptibility to oral antimircobials. Pediatr Nephrol 2002;17:173-6 https://doi.org/10.1007/s00467-001-0808-8
- Russo TA, Johnson JR. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli : ExPEC. J Infect Dis 2000;181:1753-4 https://doi.org/10.1086/315418
- Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Eschericahia coli : focus on an increasingly important endemic problem. Microbes Infect 2003;5:449-56 https://doi.org/10.1016/S1286-4579(03)00049-2
- Garau J, Xercavins M, Rodriguez-carballeira M, Gomez- Vera JR, Coll I, Vidal D, et al. Emergence and dissenmination of quinolone-resistant Escherichia coli in the community. Antimicrobial Agents Chemother 1999;43:2736-41
- Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically approved standard. NCCLS document M7-6. Wayne, PA : National Committee for Clinical Laboratory Standards, 2003
- Cheong HJ, Yoo CW, Sohn JW, Kim WJ, Kim MJ, Park SC. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea. Clin Infect Dis 2001; 33:48-53 https://doi.org/10.1086/320873
- Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001;345:1007-13 https://doi.org/10.1056/NEJMoa011265
- Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community- acquired urinary tract infections. Ann Intern Med 2001;135:41-50 https://doi.org/10.7326/0003-4819-135-1-200107030-00012
- Burman WJ, Breese PE, Murray BE, Singh KV, Batal HA, MacKenzie TD, et al. Conventional and molecular epidemiology of Trimethoprim-Sulfamethoxazole resistance among urinary Escherichia coli isolates. Am J Med 2003;115:358- 64 https://doi.org/10.1016/S0002-9343(03)00372-3
- Manges AR, Dietrch PS, Riley LW. Mutidrug-resistant Escherichia coli clonal groups causing community-acquired pyelonephritis. Clin Infect Dis 2004;38:329-34 https://doi.org/10.1086/380640
- Roh JI, Kwon YS, Oh HK, Jeong JH, Ha MC, Jeong JY. A clinical and bacteriologic study of infants and children with urinary tract infection. J Korean Pediatr Soc 1991;34:57-65
- Cha YH, Choi HR, Jong SH, Ahn YM. A clinical study on urinary tract infection in infants and children. J Korean Pediatr Soc 1994;37:1488-99
- Oh SH. Antimicrobial treatment of pediatric urinary tract infection. Korean J Pediatr Infect Dis 2003;10:55-60 https://doi.org/10.14776/kjpid.2003.10.1.55
- Lee SY, Cho SH, Kim SM, Jeong DC, Chung SY, Lee KY, et al. Urinary tract infection in febrile infants with pyuria. Korean J Pediatr Infect Dis 2004;11:90-100 https://doi.org/10.14776/kjpid.2004.11.1.90
- Gold HS, Moellering RC Jr. Antimicrobial drug resistance. N Engl J Med 2003;335:1445-53 https://doi.org/10.1056/NEJM199611073351907
-
Moon HW, Lee MA, Lee SJ. Risk factors for extendedspectrum
${\beta}$ -lactamase producing Escherichia coli from children with urinary tract infections. Korean J Microbiol 2003;6:132-8 -
Kim NH, Lee JA, Kim YK, Choi EH, Ha IS, Lee HJ, et al. Risk factors of urinary tract infections due to extendedspectrum
${\beta}$ -lactamase producing Escherichia coil in children. Korean J Pediatr 2004;47:164-9 - Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999;104:79-86 https://doi.org/10.1542/peds.104.1.79
- Brogden RN, Campoli-Richards DM. Cefixime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1989;38:524-50 https://doi.org/10.2165/00003495-198938040-00004
- Dogan R, Einhorn M, Lang R, Pomeranz A, Wolach B, Miron D, et al. Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children. Pediatr Infect Dis J 1992;11:198-203 https://doi.org/10.1097/00006454-199203000-00005
- Gok F, Duzova A, Baskin E, Ozen S, Besbas N, Bakkaloglu A. Comparative study of cefixime alone versus intramuscular ceftizoxime followed by cefixime in the treatment of urinary tract infections in children. J Chemother 2001;13:277-80 https://doi.org/10.1179/joc.2001.13.3.277
- Ansbach RK, Dybus K, Bergeson R. Uncomplicated E coli urinary tract infection in college women : A follow-up study of E. coli sensitivities to commonly prescribed antibiotics. J Am Coll Health 2005;54:81-4 https://doi.org/10.3200/JACH.54.2.81-84